2010
DOI: 10.1590/s0074-02762010000500002
|View full text |Cite
|
Sign up to set email alerts
|

Angiogenesis and experimental hepatic fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 18 publications
(17 reference statements)
1
12
0
Order By: Relevance
“…With the aid of DEI, we first re-confirm previous pathological findings such as the increase in angiogenesis over time during fibrogenesis [3], [19]. Furthermore, during the regression phase of cirrhosis the quantity of blood vessels does in fact decrease but fails to completely return to normalcy [20], [21].…”
Section: Discussionsupporting
confidence: 75%
“…With the aid of DEI, we first re-confirm previous pathological findings such as the increase in angiogenesis over time during fibrogenesis [3], [19]. Furthermore, during the regression phase of cirrhosis the quantity of blood vessels does in fact decrease but fails to completely return to normalcy [20], [21].…”
Section: Discussionsupporting
confidence: 75%
“…More specifically, the small molecule inhibitor, LY2109761, natural compound derivatives (halofuginone and quercetin), and siRNA have been used to target various components of the TGF-β pathway to mitigate inflammation, matrix deposition, and fibrosis. Integrin receptors also play an important role in cell–matrix interactions, and inhibition of α5β6 integrin with a specific antibody prevented fibrosis in a mouse model (Flechsig et al 2012; Horton et al 2013c; Lemos and Andrade 2010; Li et al 2006; Xavier et al 2004). Apart from TGF-β and its downstream effectors, targeting other signaling pathways has also yielded promising results in preclinical models.…”
Section: Methodsmentioning
confidence: 99%
“…[126][127][128][129] These processes appear to act in concert and may be co-dependently linked through chronic inflammation. 130,131 HCC relies heavily on angiogenesis to meet its metabolic needs for tumour growth and metastasis [132][133][134] and local tissue hypoxia may act as a trigger for synthesis of angiogenic factors through a HIF-1a-dependent pathway. Increased intrahepatic vascular resistance associated with cirrhosis may also stimulate compensatory vascular remodeling which further exacerbates the condition.…”
Section: Activatedmentioning
confidence: 99%